Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)
South Korea · Delayed Price · Currency is KRW 2,195.00
+50.00 (2.33%)
At close: Aug 20, 2026
Kookjeon Pharmaceutical Revenue
Kookjeon Pharmaceutical had revenue of 34.67B KRW in the quarter ending March 31, 2026, a decrease of -9.44%. This brings the company's revenue in the last twelve months to 127.43B, down -5.92% year-over-year. In the year 2025, Kookjeon Pharmaceutical had annual revenue of 131.04B, down -3.98%.
Revenue (ttm)
127.43B
Revenue Growth
-5.92%
P/S Ratio
0.88
Revenue / Employee
756.02M
Employees
178
Market Cap
118.50B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 131.04B | -5.43B | -3.98% |
| Dec 31, 2024 | 136.47B | 14.47B | 11.86% |
| Dec 31, 2023 | 122.00B | 18.29B | 17.63% |
| Dec 31, 2022 | 103.71B | 18.36B | 21.51% |
| Dec 31, 2021 | 85.35B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| FarmStory | 1.45T |
| KCC Engineering & Construction | 1.28T |
| KX Innovation | 354.87B |
| Keeps Biopharma | 188.94B |
| Hyundai Ezwel | 146.05B |
| Sung Woo Co.,Ltd | 85.41B |
| Avatec | 74.97B |
| Pureun Savings Bank | 56.11B |